John Atherton is Director of Cardiology (Royal Brisbane and Women’s Hospital), Associate Professor (University of Queensland), Adjunct Professor (Queensland University of Technology), Honorary Fellow (University of Melbourne) and Pre-eminent Staff Specialist (Queensland Health). He sat on the Board of the Cardiac Society of Australia and New Zealand (CSANZ) (2009-2016) and chaired the CSANZ Professional Ethics Standards Committee, the CSANZ Heart Failure Council and the Asia-Pacific Acute Decompensated Heart Failure Registry SAC.
Dr Atherton is an appointed member of the Australian Government Medical Services Advisory Committee (2003-2018) and sits on the Heart Foundation Research Committee. He currently chairs the Working Group for the National Heart Foundation of Australia and CSANZ Heart Failure guidelines and was an official content reviewer for the 2016 European Society of Cardiology Heart Failure guidelines. He chairs the Queensland Heart Failure Reporting Outcomes (HERO) registry and co-chairs the Statewide Heart Failure Service Steering Committee.
Dr Atherton’s research interests include heart failure epidemiology, investigating methods to detect presymptomatic heart disease, and cardiac genetics. He is collaborating with Prof Sanjoy Paul (University of Melbourne and Director Melbourne Epicentre, The Royal Melbourne Hospital) to characterise the prevalence and predictors of under- and over-treatment in diabetes mellitus and determine the association between old and new anti-diabetes drugs and the risk of heart failure.